ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Earnings Call

Abate As Industries Earnings Call: Key Takeaways

Abate AS Industries reported strong Q4 FY2026 results, highlighting a strategic transition from platform building to scaling, driven by its healthcare segment expansion.

Why this was an Alfa AlertNot a filter event. High growth is vs previous year, not against guided upper-end targets.
Highlights
Revenue growth67% YoY growth in FY2026 to ₹161.68cr.
MarginsTargeting 18-20% EBITDA margins over the medium term.
Demand visibilityStrong demand in Ophthalmology and specialized eye care.
Management confidenceHigh; citing FY2026 as an important validation year.

Growth

FY2026 revenue grew 67% to ₹161.88cr. PAT increased over 10-fold to ₹12.3cr from ₹1.1cr in FY2025.

Outlook

Targeting 18-20% EBITDA margins; planned ₹50cr capex for expansion; aiming for 70-80% healthcare revenue mix.

Risks

Fragmented eye care market and potential delays in institutional/TPA receivables settlement cycles.

Source

Earnings Call filed with BSE, NSE: TRIJAL. Summary written with AI assistance from the document.

Read the document ↗

Abate As Industries Ltd: key numbers

Share price
₹7.52
Market cap
₹118.5 Cr
Revenue (annual)
₹159.4 Cr
Net profit (annual)
₹8.59 Cr
P/E (TTM)
9.6×Sector 54.5×
Promoter holding
32.42%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Abate As Industries Ltd

All →
17:11 IST BSE
Partnership

Abate As Industries Partnership

Abate AS Industries Ltd entered a service agreement with Franchise India Brands Limited to expand its eye hospital franchise network. The agreement spans 24 months.

Value
₹0.30 Cr
From
Franchise India Brands Limited
Execution
24 months